In view of the rising cost of materials, we note that SCOMNET has performed a revision on their products pricing in April 2022. To keep margins intact and little signs of tapering of inflationary pressure, the second revision of product pricing were also performed during August 2022. Moving forward, we reckon that net margins could chalk in slightly above 20.0% mark in subsequent quarters amid the favourable exchange rates, coupled with the gradual introduction of new medical devices that yields decent margins.
Open an Account with M+ Online and begin your investment journey today